ARTICLE | Clinical News
Onexton Gel clindamycin phosphate/benzoyl peroxide regulatory update
December 22, 2014 8:00 AM UTC
FDA approved Onexton Gel clindamycin phosphate/benzoyl peroxide from Valeant to treat acne vulgaris in patients ages =12 years. Valeant said it plans to launch the fixed combination of 1.2% clindamyci...